Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

$24.7 Billion Says Gilead Is Up to Something
Mass Device
Wed, 09/23/15 - 10:17 am
Tags:
Gilead Sciences
After Harvoni: A pangenotype hep C combo could be Gilead's next breakthrough
BioPharma Dive
Tue, 09/22/15 - 11:45 am
Tags:
Gilead Sciences, Harvoni, hepatitis C, Sovaldi
Biotech Index Led By Biogen And Gilead Sciences Tanks On Clinton’s Tweet; Will The Impact Last?
Bidness, ETC
Tue, 09/22/15 - 09:39 am
Tags:
Hillary Clinton, biotech, Gilead Sciences, drug pricing
Johnson & Johnson And Achillion Pharmaceuticals May Offer Fastest 100% Cure With Their HCV Combo
Bidness, ETC
Fri, 09/18/15 - 10:56 am
Tags:
JNJ, Achillion, hepatitis C, Sovaldi, Gilead Sciences, ACH-3102, odalasvir
Could These 2 Biopharmas Be the Real Apples of Gilead Sciences' Eye?
Motley Fool
Thu, 09/17/15 - 10:00 am
Tags:
Gilead Sciences, Baxalta, Incyte, M&A
Biotechs Coming Off One Of The Busiest Weeks In Recent Memory
Yahoo/Benzinga
Tue, 09/15/15 - 09:04 am
Tags:
biotech, Gilead Sciences, Akebia, Vitae, Clovis Oncology, AstraZeneca, Bristol-Myers Squibb, Flexion, Tetraphase Pharmaceuticals
2 new studies show Gilead's Truvada extremely effective for HIV prevention
BioPharma Dive
Mon, 09/14/15 - 12:08 pm
Tags:
Gilead Sciences, Truvada, HIV
The Medicare Gravy Train Into Big Pharma's Pockets Keeps Growing
Seeking Alpha
Mon, 09/14/15 - 10:57 am
Tags:
Medicare, Medicaid, AstraZeneca, Gilead Sciences, Merck, Pfizer, Sanofi
Could Major Acquisition Boost Gilead?
Seeking Alpha
Sun, 09/13/15 - 11:59 am
Tags:
M&A, Gilead Sciences
Gilead combo HIV pill matches Truvada efficacy but safer in trial
Yahoo/Reuters
Wed, 09/2/15 - 10:20 am
Tags:
Gilead Sciences, HIV, Truvada, clinical trials, F/TAF
Gilead & Amgen Account for Nearly 75% of the Biotech Profit Pool
Barron's
Sat, 08/29/15 - 09:03 am
Tags:
Gilead Sciences, Amgen, biotech
Why Gilead Sciences, Inc. Can Easily Take Over Bristol-Myers Squibb Co
Bidness, ETC
Thu, 08/27/15 - 09:52 am
Tags:
Gilead Sciences, Bristol-Myers Squibb, M&A
White House urged to stop states' 'rationing' of hep C drugs
Fierce Pharma
Wed, 08/26/15 - 11:56 am
Tags:
hepatitis C, Medicaid, Harvoni, Gilead Sciences, AbbVie, Viekira Pak
Gilead Sciences, Inc. Harvoni Vs. AbbVie Inc Humira: Which Would Be Best-Selling Drug Of 2015?
Bidness, ETC
Tue, 08/25/15 - 08:56 am
Tags:
Gilead Sciences, Harvoni, AbbVie, Humira
Gilead Sciences: Hep-C Prescriptions Still Slowing
Barron's
Fri, 08/21/15 - 05:20 pm
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi
After Curing Hepatitis C, Gilead Works to Vanquish More Viruses
Bloomberg
Mon, 08/17/15 - 07:15 pm
Tags:
Gilead Sciences, hepatitis C, hepatitis B, GS-9620, viruses
Celgene Vs. Gilead: Vetting for the Best Biopharma
Investopedia
Fri, 08/14/15 - 09:43 am
Tags:
Celgene, Gilead Sciences
Did Gilead Sciences Just Give Wall Street a Huge Head Fake?
Motley Fool
Sun, 08/9/15 - 11:21 am
Tags:
Gilead Sciences, Zydelig, blood cancer
Merck Targets Toughest Cases to Gain Hepatitis C Foothold
Bloomberg
Mon, 08/3/15 - 05:10 pm
Tags:
Merck, Gilead Sciences, AbbVie, hepatitis C, Viekira Pak, Harvoni, Sovaldi, grazoprevir/elbasvir
Gilead Won’t Run Out of Hep C Patients, or Dollars, Anytime Soon
Bloomberg
Thu, 07/30/15 - 10:36 am
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.